Abstract
This report describes the synthesis, structure-activity relationships and activity of piperidine, homopiperidine, and azocane derivatives combining NK1 receptor (NK1R) antagonism and serotonin reuptake transporter (SERT) inhibition. Our studies culminated in the discovery of piperidine 2 and homopiperidine 8 as potent dual NK1R antagonists-SERT inhibitors. Compound 2 demonstrated significant activity in the gerbil forced swimming test, suggesting that dual NK1R antagonists-SERT inhibitors may be useful in treating depression disorders.
Copyright © 2013 Elsevier Ltd. All rights reserved.
MeSH terms
-
Antidepressive Agents / chemistry
-
Antidepressive Agents / pharmacology
-
Astrocytes / cytology
-
Astrocytes / drug effects
-
Cell Line
-
HEK293 Cells
-
Humans
-
Neurokinin-1 Receptor Antagonists / chemistry*
-
Neurokinin-1 Receptor Antagonists / pharmacology*
-
Piperidines / chemical synthesis
-
Piperidines / chemistry*
-
Piperidines / pharmacology*
-
Receptors, Neurokinin-1 / metabolism
-
Selective Serotonin Reuptake Inhibitors / chemical synthesis
-
Selective Serotonin Reuptake Inhibitors / chemistry*
-
Selective Serotonin Reuptake Inhibitors / pharmacology*
-
Serotonin Plasma Membrane Transport Proteins / biosynthesis
-
Serotonin Plasma Membrane Transport Proteins / genetics
-
Structure-Activity Relationship
Substances
-
Antidepressive Agents
-
Neurokinin-1 Receptor Antagonists
-
Piperidines
-
Receptors, Neurokinin-1
-
SLC6A4 protein, human
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Uptake Inhibitors